Published in Front Endocrinol (Lausanne) on April 24, 2014
Control of brain development, function, and behavior by the microbiome. Cell Host Microbe (2015) 1.48
NeuroPep: a comprehensive resource of neuropeptides. Database (Oxford) (2015) 0.83
Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence? Int J Obes (Lond) (2015) 0.79
Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior. Curr Neuropharmacol (2016) 0.78
Molecular pathways associated with the nutritional programming of plant-based diet acceptance in rainbow trout following an early feeding exposure. BMC Genomics (2016) 0.78
A predictive model of the dynamics of body weight and food intake in rats submitted to caloric restrictions. PLoS One (2014) 0.78
Appetite regulation is independent of the changes in ghrelin levels in pregnant rats fed low-protein diet. Physiol Rep (2015) 0.76
The Neuroendocrine Regulation of Food Intake in Fish: A Review of Current Knowledge. Front Neurosci (2016) 0.76
Bisphenol A Interaction With Brain Development and Functions. Dose Response (2015) 0.76
Correlation of Brain Neuropeptide (Nesfatin-1 and Orexin-A) Concentrations with Anthropometric and Biochemical Parameters in Malnourished Children. J Clin Res Pediatr Endocrinol (2015) 0.75
Obese neuronal PPARγ knock-out mice are leptin sensitive but show impaired glucose tolerance and fertility. Endocrinology (2016) 0.75
Blunted hypothalamic ghrelin signaling reduces diet intake in rats fed a low-protein diet in late pregnancy. Physiol Rep (2015) 0.75
Involvement of Astrocytes in Mediating the Central Effects of Ghrelin. Int J Mol Sci (2017) 0.75
Hypothalamic sensing of ketone bodies after prolonged cerebral exposure leads to metabolic control dysregulation. Sci Rep (2016) 0.75
Changes in circulating leptin levels during the initial stage of cessation are associated with smoking relapse. Psychopharmacology (Berl) (2015) 0.75
Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy. Immunotargets Ther (2015) 0.75
Central Administration of 1-Deoxynojirimycin Attenuates Hypothalamic Endoplasmic Reticulum Stress and Regulates Food Intake and Body Weight in Mice with High-Fat Diet-Induced Obesity. Evid Based Complement Alternat Med (2017) 0.75
Acute Consumption of Resistant Starch Reduces Food Intake but Has No Effect on Appetite Ratings in Healthy Subjects. Nutrients (2017) 0.75
The relationship between weight gain during pregnancy and allopregnanolone levels: a longitudinal study. Endocr Connect (2017) 0.75
Central nervous system control of food intake. Nature (2000) 15.85
Effects of the obese gene product on body weight regulation in ob/ob mice. Science (1995) 13.57
Central nervous system control of food intake and body weight. Nature (2006) 11.89
Environmental contributions to the obesity epidemic. Science (1998) 11.87
Ghrelin induces adiposity in rodents. Nature (2000) 10.18
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med (2002) 9.91
The physiology of glucagon-like peptide 1. Physiol Rev (2007) 9.07
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med (1995) 8.51
A role for ghrelin in the central regulation of feeding. Nature (2001) 8.12
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science (1997) 6.23
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
Obesity wars: molecular progress confronts an expanding epidemic. Cell (2004) 5.29
Lipid-induced insulin resistance: unravelling the mechanism. Lancet (2010) 4.88
Diabetes, obesity, and the brain. Science (2005) 4.59
Circulating ghrelin levels are decreased in human obesity. Diabetes (2001) 4.28
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology (2000) 4.27
Leptin enters the brain by a saturable system independent of insulin. Peptides (1996) 3.97
Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest (2005) 3.92
Metabolic syndrome: definitions and controversies. BMC Med (2011) 3.80
A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature (1996) 3.79
Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol (2003) 3.78
Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62
The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol (1992) 3.53
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology (2001) 3.40
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest (2005) 3.34
Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature (2006) 3.19
Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci (1998) 3.17
The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology (2002) 3.17
Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab (2006) 3.14
The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A (1998) 2.91
Distribution of orexin receptor mRNA in the rat brain. FEBS Lett (1998) 2.90
Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav (2006) 2.71
Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest (1985) 2.64
Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab (2002) 2.62
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol (1997) 2.59
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
Absence of ghrelin protects against early-onset obesity. J Clin Invest (2005) 2.53
Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron (1998) 2.46
GOAT links dietary lipids with the endocrine control of energy balance. Nat Med (2009) 2.42
The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord (2000) 2.28
The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci (2002) 2.26
Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab (2006) 2.23
Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis (2007) 2.21
Gut hormones and appetite control. Gastroenterology (2007) 2.16
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology (2003) 2.14
The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab (2008) 2.11
Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab (2011) 1.99
Appetite control. J Endocrinol (2005) 1.97
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab (2001) 1.97
Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res (2004) 1.96
Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes (2002) 1.95
Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology (2009) 1.90
Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med (1998) 1.83
Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. Am J Physiol Regul Integr Comp Physiol (2003) 1.82
Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes (2001) 1.82
Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol (2009) 1.73
Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett (2002) 1.73
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med (1998) 1.70
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol (1997) 1.67
Role of neuropeptides in appetite regulation and obesity--a review. Neuropeptides (2006) 1.67
Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab (2009) 1.66
Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology (2007) 1.64
Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol (2004) 1.64
Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology (2005) 1.63
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci (2006) 1.62
Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res (1986) 1.60
GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol (1999) 1.60
The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology (2005) 1.58
The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther (2007) 1.57
Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes (2005) 1.57
Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes (1999) 1.57
Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol (2008) 1.53
The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci (2006) 1.53
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Hormonal regulation of food intake. Physiol Rev (2005) 1.50
Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol (2003) 1.50
Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab (2003) 1.49
Review article: a comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther (2012) 1.48
Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology (1994) 1.48
The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem (1993) 1.47
Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol (2002) 1.45
Vaccination against weight gain. Proc Natl Acad Sci U S A (2006) 1.45
Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol (1999) 1.39
Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet (2002) 1.36
Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab (2004) 1.35
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance. Obesity (Silver Spring) (2006) 1.34
A second look at the barriers of the medial basal hypothalamus. Exp Brain Res (2000) 1.29
Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol (2004) 1.29
Bombesin suppresses feeding in rats. Nature (1979) 1.28
Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure. Biochem Biophys Res Commun (1992) 1.25
Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes (2000) 1.22
Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur J Neurosci (2004) 1.21
Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides (2006) 1.21